Progress in ERX-315 Phase 1 Clinical Trial

Innovative cancer therapy demonstrates favorable safety profile — Dallas, Texas — June 26, 2025: Etira, a clinical-stage biopharmaceutical company developing breakthrough cancer therapies, announced today that the first patient has been…

Etira Expands Clinical Trial Sites

Sydney, Australia – June 2, 2025: Etira, a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies, announced the activation of a new trial site at Macquarie University Hospital (MUH) in Sydney, New South…